A Randomized Comparative Study to Evaluate Effectiveness of Arundo Mauritanica versus Individualized Homoeopathic Medicine for Allergic Rhinitis
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- To evaluate the change in allergic rhinitis symptoms using the Total Nasal Symptom Score (TNSS) in both groups.
研究概览
简要总结
This study aims to assess and compare the therapeutic outcomes of a specific remedy, Arundo mauritanica, with individualized constitutional homeopathic treatment in allergic rhinitis patients. It will be conducted as a double-blind randomized trial on 60 participants, using validated tools such as the Total Nasal Symptom Score (TNSS), Mini Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), and serum IgE levels. Study duration is of 16 months. The study intends to generate clinical evidence to bridge the gap in research on Arundo’s role and provide clarity on its effectiveness relative to individualized homeopathy in improving symptoms and quality of life
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 59.00 Year(s)（—）
- 性别
- All
入选标准
- •Clinically diagnosed cases of allergic rhinitis according to ARIA guidelines Participants with mild to moderate symptoms of allergic rhinitis.
- •Willing to provide written informed consent.
- •Participants who have not taken anti-allergic medications for at least 2 weeks prior to enrollment.
排除标准
- •Participants with nasal polyps, deviated nasal septum, chronic sinusitis, asthma, or other systemic illnesses.
- •Participants already under long-term antihistamines, corticosteroids, or immunotherapy.
- •Pregnant or lactating women.
- •Participants with any life-threatening illnesses (e.g., malignancies, uncontrolled systemic diseases) or classified as part of a vulnerable population.
- •Participants with psychiatric disorders or cognitive impairment affecting their ability to give consent or adhere to protocol.
- •Participants already participating in another clinical trials.
结局指标
主要结局
To evaluate the change in allergic rhinitis symptoms using the Total Nasal Symptom Score (TNSS) in both groups.
时间窗: 6 months for patient recruitment and intervention | 6 months for follow ups | 2 months for data analysis and interpretation | 2 months of report writing.
次要结局
- To assess the improvement in quality of life using the Mini Rhinoconjunctivitis Quality of Life Questionnaire.(Evaluate changes in serum IgE levels pre- and post treatment.)
研究者
Amit Prakash Yadav
Bakson Homoeopathic Medical College and Hospital